Structure-activity study of L-cysteine-based N-type calcium channel blockers: Optimization of N- and C-terminal substituents

被引：18

作者：

Seko, T ^{[1
]}

Kato, M ^{[1
]}

Kohno, H ^{[1
]}

Ono, S ^{[1
]}

Hashimura, K ^{[1
]}

Takimizu, H ^{[1
]}

Nakai, K ^{[1
]}

Maegawa, H ^{[1
]}

Katsube, N ^{[1
]}

Toda, M ^{[1
]}

机构：

[1] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 06期

关键词：

D O I：

10.1016/S0960-894X(02)00032-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Synthesis and structure-activity relationship (SAR) studies of L-cysteine-based N-type calcium channel blockers are described. In the course of exploring SAR of the N- and C-terminal substituents, the L-cysteine derivative 4b was found to be a potent N-type calcium channel blocker with an IC50 value of 0.14 muM on IMR-32 assay. Compound 4b showed 12-fold selectivity for N-type over L-type calcium channels on AtT-20 assay. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：915 / 918

页数：4

共 50 条

[21] STRUCTURE-ACTIVITY ANALYSIS OF A CONUS PEPTIDE BLOCKER OF N-TYPE NEURONAL CALCIUM CHANNELS
NADASDI, L
YAMASHIRO, D
CHUNG, D
TARCZYHORNOCH, K
ADRIAENSSENS, P
RAMACHANDRAN, J
BIOCHEMISTRY, 1995, 34 (25) : 8076 - 8081
[22] Structure-activity relationships of ω-conotoxins at N-type voltage-sensitive calcium channels
Nielsen, KJ
Schroeder, T
Lewis, R
JOURNAL OF MOLECULAR RECOGNITION, 2000, 13 (02) : 55 - 70
[23] Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonists
Ryder, TR
Hu, LY
Rafferty, MF
Lotarski, SM
Rock, DM
Stoehr, SJ
Taylor, CP
Weber, ML
Miljanich, GP
Millerman, E
Szoke, BG
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2453 - 2458
[24] The combined effects of N-type calcium channel blockers and morphine on Aδ versus C fiber mediated nociception
Pirec, V
Laurito, CE
Lu, Y
Yeomans, DC
ANESTHESIA AND ANALGESIA, 2001, 92 (01): : 239 - 243
[25] Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of pain
Wall, Mark J.
Subasinghe, Nalin L.
Winters, Michael P.
Lubin, Mary Lou
Finley, Michael F. A.
Qin, Ning
Brandt, Michael R.
Neeper, Michael P.
Schneider, Craig R.
Colburn, Raymond W.
Flores, Christopher M.
Sui, Zhihua
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (23-24) : 3780 - 3783
[26] Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels
Yamamoto, T
Niwa, S
Ohno, S
Onishi, T
Matsueda, H
Koganei, H
Uneyama, H
Fujita, SI
Takeda, T
Kito, M
Ono, Y
Saitou, Y
Takahara, A
Iwata, S
Shoji, M
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) : 798 - 802
[27] T-Type and N-Type Calcium Channel Blockers Attenuate Cardiac Sympathetic Nervous Activity More Effectively Compared With L-Type Calcium Channel Blocker in Patients with Hypertension
Ogura, Chika
Miyamoto, Shoichi
Ikai, Akiko
Tanaka, Shiro
Fujita, Masatoshi
CIRCULATION, 2011, 124 (21)
[28] Renoprotective Advantage of an L/N-Type Calcium Channel Blocker Compared With L-Type Calcium Channel Blockers in Type 2 Diabetic Patients With Early-Stage Nephropathy
Fukumoto, Shinya
Ishimura, Eiji
Takeda, Koji
Mima, Yohei
Motoyama, Koka
Morioka, Tomoaki
Mori, Katsuhito
Shoji, Tetsuo
Emoto, Masanori
Nishizawa, Yoshiki
Inaba, Masaaki
DIABETES, 2012, 61 : A143 - A144
[29] Modulation of N-type calcium channel activity by G-proteins and protein kinase C
Barrett, CF
Rittenhouse, AR
JOURNAL OF GENERAL PHYSIOLOGY, 2000, 115 (03): : 277 - 286
[30] Different Effects of L/N-Type and L-Type Calcium Channel Blockers on the Renin-Angiotensin-Aldosterone System in SHR/Izm
Konda, Tomoyuki
Enomoto, Azusa
Aritomi, Shizuka
Niinuma, Kazumi
Koganei, Hajime
Ogawa, Tetsuya
Nitta, Kosaku
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 30 (02) : 155 - 161

← 1 2 3 4 5 →